KNSA - Latest News
Kiniksa Pharmaceuticals, Ltd. (KNSA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $4.44B. Trailing twelve-month P/E ratio is 61.92. Beta to the broader market is 0.17.
The article list below shows the most recent KNSA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent KNSA Headlines
Kiniksa: Increased Outlook For Arcalyst, Augmented By Pipeline Maturation
seekingalpha.com - Apr 29, 2026
Kiniksa Pharmaceuticals continues to outperform, with Arcalyst net sales poised to surpass my previous bullish estimates. Arcalyst captured 18% of th
Breakfast News: Enphase Dips As Solar Demand Dims
fool.com - Apr 29, 2026
Enphase suffers from weaker U. S.
Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today
fool.com - Apr 28, 2026
Its Arcalyst has been on the market for years, yet it posted strong sales growth in the period. More is to come, apparently, as management raised its
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript
seekingalpha.com - Apr 28, 2026
Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript
Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates
zacks.com - Apr 28, 2026
Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0. 27 per share, beating the Zacks Consensus Estimate of $0.
How News Affects KNSA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track KNSA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked KNSA news questions
- What is the latest KNSA news headline?
- The most recent KNSA headline (Apr 29, 2026) is "Kiniksa: Increased Outlook For Arcalyst, Augmented By Pipeline Maturation". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the KNSA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What KNSA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual KNSA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.